Corrigendum: Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological and Molecular Features

Corrigendum: Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological and Molecular Features

Bibliographic Details
Main Authors: Mingxiao Li, Xiaohui Ren, Gehong Dong, Jincheng Wang, Haihui Jiang, Chuanwei Yang, Xuzhe Zhao, Qinghui Zhu, Yong Cui, Kefu Yu, Song Lin
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
pseudoprogression
MGMT promoter methylation
subventricular zone
IDH wild-type
glioblastoma
random forest
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.700599/full
id doaj-1867bcb4c2e74db9a9bab41ff53e908d
record_format Article
spelling doaj-1867bcb4c2e74db9a9bab41ff53e908d2021-05-19T13:40:06ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-05-011110.3389/fonc.2021.700599700599Corrigendum: Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological and Molecular FeaturesMingxiao Li0Xiaohui Ren1Gehong Dong2Jincheng Wang3Haihui Jiang4Chuanwei Yang5Xuzhe Zhao6Qinghui Zhu7Yong Cui8Kefu Yu9Song Lin10Song Lin11Song Lin12Department of Neurosurgery, National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurosurgery, National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Pathology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Radiology, Peking University Cancer Hospital, Beijing, ChinaDepartment of Neurosurgery, National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurosurgery, National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurosurgery, National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurosurgery, National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurosurgery, National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurosurgery, National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaBeijing Key Laboratory of Brain Tumor, Center of Brain Tumor, Institute for Brain Disorders, Beijing, ChinaDepartment of Neurosurgery, Beijing Neurosurgical Institute, Capital Medical University, Beijing, Chinahttps://www.frontiersin.org/articles/10.3389/fonc.2021.700599/fullpseudoprogressionMGMT promoter methylationsubventricular zoneIDH wild-typeglioblastomarandom forest
collection DOAJ
language English
format Article
sources DOAJ
author Mingxiao Li
Xiaohui Ren
Gehong Dong
Jincheng Wang
Haihui Jiang
Chuanwei Yang
Xuzhe Zhao
Qinghui Zhu
Yong Cui
Kefu Yu
Song Lin
Song Lin
Song Lin
spellingShingle Mingxiao Li
Xiaohui Ren
Gehong Dong
Jincheng Wang
Haihui Jiang
Chuanwei Yang
Xuzhe Zhao
Qinghui Zhu
Yong Cui
Kefu Yu
Song Lin
Song Lin
Song Lin
Corrigendum: Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological and Molecular Features
Frontiers in Oncology
pseudoprogression
MGMT promoter methylation
subventricular zone
IDH wild-type
glioblastoma
random forest
author_facet Mingxiao Li
Xiaohui Ren
Gehong Dong
Jincheng Wang
Haihui Jiang
Chuanwei Yang
Xuzhe Zhao
Qinghui Zhu
Yong Cui
Kefu Yu
Song Lin
Song Lin
Song Lin
author_sort Mingxiao Li
title Corrigendum: Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological and Molecular Features
title_short Corrigendum: Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological and Molecular Features
title_full Corrigendum: Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological and Molecular Features
title_fullStr Corrigendum: Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological and Molecular Features
title_full_unstemmed Corrigendum: Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological and Molecular Features
title_sort corrigendum: distinguishing pseudoprogression from true early progression in isocitrate dehydrogenase wild-type glioblastoma by interrogating clinical, radiological and molecular features
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2021-05-01
topic pseudoprogression
MGMT promoter methylation
subventricular zone
IDH wild-type
glioblastoma
random forest
url https://www.frontiersin.org/articles/10.3389/fonc.2021.700599/full
work_keys_str_mv AT mingxiaoli corrigendumdistinguishingpseudoprogressionfromtrueearlyprogressioninisocitratedehydrogenasewildtypeglioblastomabyinterrogatingclinicalradiologicalandmolecularfeatures
AT xiaohuiren corrigendumdistinguishingpseudoprogressionfromtrueearlyprogressioninisocitratedehydrogenasewildtypeglioblastomabyinterrogatingclinicalradiologicalandmolecularfeatures
AT gehongdong corrigendumdistinguishingpseudoprogressionfromtrueearlyprogressioninisocitratedehydrogenasewildtypeglioblastomabyinterrogatingclinicalradiologicalandmolecularfeatures
AT jinchengwang corrigendumdistinguishingpseudoprogressionfromtrueearlyprogressioninisocitratedehydrogenasewildtypeglioblastomabyinterrogatingclinicalradiologicalandmolecularfeatures
AT haihuijiang corrigendumdistinguishingpseudoprogressionfromtrueearlyprogressioninisocitratedehydrogenasewildtypeglioblastomabyinterrogatingclinicalradiologicalandmolecularfeatures
AT chuanweiyang corrigendumdistinguishingpseudoprogressionfromtrueearlyprogressioninisocitratedehydrogenasewildtypeglioblastomabyinterrogatingclinicalradiologicalandmolecularfeatures
AT xuzhezhao corrigendumdistinguishingpseudoprogressionfromtrueearlyprogressioninisocitratedehydrogenasewildtypeglioblastomabyinterrogatingclinicalradiologicalandmolecularfeatures
AT qinghuizhu corrigendumdistinguishingpseudoprogressionfromtrueearlyprogressioninisocitratedehydrogenasewildtypeglioblastomabyinterrogatingclinicalradiologicalandmolecularfeatures
AT yongcui corrigendumdistinguishingpseudoprogressionfromtrueearlyprogressioninisocitratedehydrogenasewildtypeglioblastomabyinterrogatingclinicalradiologicalandmolecularfeatures
AT kefuyu corrigendumdistinguishingpseudoprogressionfromtrueearlyprogressioninisocitratedehydrogenasewildtypeglioblastomabyinterrogatingclinicalradiologicalandmolecularfeatures
AT songlin corrigendumdistinguishingpseudoprogressionfromtrueearlyprogressioninisocitratedehydrogenasewildtypeglioblastomabyinterrogatingclinicalradiologicalandmolecularfeatures
AT songlin corrigendumdistinguishingpseudoprogressionfromtrueearlyprogressioninisocitratedehydrogenasewildtypeglioblastomabyinterrogatingclinicalradiologicalandmolecularfeatures
AT songlin corrigendumdistinguishingpseudoprogressionfromtrueearlyprogressioninisocitratedehydrogenasewildtypeglioblastomabyinterrogatingclinicalradiologicalandmolecularfeatures
_version_ 1721436420905631744

Similar Items